Thomas Soloway, an investor and pharmaceutical executive, has become the chief financial offer of Ascendis Pharma A/S, a specialty pharma company which re-positions marketed drugs. Mr Soloway joins Ascendis from Transcept Pharmaceuticals Inc, where he was a co-founder and chief operating officer, helping lead the company through its transition from a private to a public enterprise. Earlier in his career, Mr Soloway was a principal at Montreux Equity Partners.
Ascendis Pharma announced the appointment on 9 January 2014.
Copyright 2014 Evernow Publishing Ltd